Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the ...

Bengaluru-based biopharma firm Biocon on Thursday reported a consolidated net profit of Rs 25.1 crore in the third quarter of the financial year 2024-25 (Q3FY25). During the same period in the ...

Q3 2025 Management View CEO David Cataford highlighted that despite operational challenges, the company produced over 3.6 million tonnes and sold nearly 3.3 million tonnes during the quarter. He noted ...

The board has declared 3rd interim dividend for FY 2024-25 of 85% cash reward for shareholders. A dividend is always ...

Occidental Petroleum's fundamentals and valuation have improved, presenting a long-term buying opportunity amid oil and gas market volatility. Learn more on OXY stock here.

Chief Executive Officer Carol Tome made the comment on the company’s Q4 earnings call.Invest with Confidence: Follow TipRanks' Top ...

U.S. gross domestic product grew by 2,3% in Q4 2024 after expanding by 3.1% in Q3. Consumption was the lion's share of growth as investment fell on inventory declines.

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look ...

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look ...

India's Larsen & Toubro reported a third-quarter profit miss on Thursday, and said its quarterly order growth quickened ...

But today, Freshworks is emphatically both an American company with 70,000 customers worldwide, and a global one. So says ...

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...